Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 15/20 | 0.32 |
| ▸ | ITGAV | P06756 | 15/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14066100 | 0.87 | — | — | |
| SCHEMBL14066088 | 0.70 | HTR2C (0.32) | — | |
| SCHEMBL18574255 | 0.68 | ALDH1A1 (0.36) | ITGB3ITGAV | |
| SCHEMBL1488932 | 0.54 | MEN1 (0.58) | — | |
| SCHEMBL16611765 | 0.53 | ALDH1A1 (0.49) | — | |
| SCHEMBL31341669 | 0.52 | SMN1; SMN2 (0.49) | — | |
| SCHEMBL16980452 | 0.52 | MEN1 (0.52) | — | |
| SCHEMBL1488930 | 0.52 | HTR2C (0.48) | — | |
| SCHEMBL9195578 | 0.51 | SMN1; SMN2 (0.63) | — | |
| SCHEMBL541558 | 0.51 | MEN1 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7427672-B2 | Artificial nucleic acids of n-o bond crosslinkage type | Imanishi, Takeshi (JP) | 2008-09-23 | — | — | US | disclosed |
| US-20070167387-A1 | Novel artificial nucleic acids of n-o bond crosslinkage type | TAKESHI IMANISHI (JP) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167387-A1 | Novel artificial nucleic acids of n-o bond crosslinkage type | RNGTT, NSUN2, POLR2H | ITGB3 2934/4885ITGAV 2616/4885ITGA2B 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.